Abpro Holdings, Inc. — Investor Relations & Filings
Abpro Holdings, Inc. is a clinical-stage biotechnology company that develops next-generation antibody therapeutics. The company focuses on creating novel antibody constructs for challenging and high-value targets in immuno-oncology and ophthalmology. Its pipeline includes therapies targeting various cancers such as HER2-positive (HER2+) breast and gastric cancers, as well as non-HER2+ gastric, colorectal, and liver cancers. In ophthalmology, Abpro is developing treatments for conditions like wet age-related macular degeneration. The company utilizes its proprietary DiversImmune™ platform to engineer and discover its therapeutic candidates, aiming to address severe and life-threatening diseases with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2026-05-20 | English | |
| 10-K - Abpro Holdings, Inc. (0001893219) (Filer) | 2026-04-15 | English | |
| 8-K - ABPRO HOLDINGS, INC. (0001893219) (Filer) | 2026-02-20 | English | |
| 8-K Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-02-03 | English | |
| CURRENT REPORT | 2026-01-23 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 46694579 | QUARTERLY REPORT | 2026-05-20 | English | ||
| 34613638 | 10-K - Abpro Holdings, Inc. (0001893219) (Filer) | 2026-04-15 | English | ||
| 32900395 | 8-K - ABPRO HOLDINGS, INC. (0001893219) (Filer) | 2026-02-20 | English | ||
| 32182522 | 8-K Filing | 2026-02-11 | English | ||
| 32182442 | 8-K Filing | 2026-02-03 | English | ||
| 13546405 | CURRENT REPORT | 2026-01-23 | English | ||
| 13546408 | CURRENT REPORT | 2026-01-06 | English | ||
|
2025
8 filings
| |||||
| 13546406 | CURRENT REPORT | 2025-12-15 | English | ||
| 13546407 | CURRENT REPORT | 2025-12-09 | English | ||
| 13546413 | Regulatory Filings 2025 | 2025-12-03 | English | ||
| 13546417 | AMENDMENT NO. 1 TO FORM S-1 | 2025-11-28 | English | ||
| 13546418 | PROSPECTUS SUPPLEMENT | 2025-11-17 | English | ||
| 13546420 | QUARTERLY REPORT | 2025-11-14 | English | ||
| 13546480 | REGISTRATION STATEMENT | 2025-11-07 | English | ||
| 13546499 | AMENDMENT NO. 1 TO FORM 8-K | 2025-11-04 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
Abpro Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34955/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34955 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34955 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34955 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34955}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Abpro Holdings, Inc. (id: 34955)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.